|HIV treatment adherence, drug resistance, virologic failure: evolving concepts|
J B Nachega, V C Marconi, G U van Zyl, E M Gardner, W Preiser, ...
Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious …, 2011
|Emergence of HIV drug resistance during first-and second-line antiretroviral therapy in resource-limited settings|
MC Hosseinipour, RK Gupta, G Van Zyl, JJ Eron, JB Nachega
The Journal of infectious diseases 207 (suppl_2), S49-S56, 2013
|Adult antiretroviral therapy guidelines 2017|
G Meintjes, MA Moorhouse, S Carmona, N Davies, S Dlamini, ...
Southern African journal of HIV medicine 18 (1), 2017
|Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa|
H Tegally, E Wilkinson, M Giovanetti, A Iranzadeh, V Fonseca, ...
|Low lopinavir plasma or hair concentrations explain second line protease inhibitor failures in a resource-limited setting|
GU Van Zyl, TE Van Mens, H McIlleron, M Zeier, JB Nachega, E Decloedt, ...
Journal of acquired immune deficiency syndromes (1999) 56 (4), 333, 2011
|Significantly diminished long-term specificity of the BED capture enzyme immunoassay among patients with HIV-1 with very low CD4 counts and those on antiretroviral therapy|
ET Marinda, J Hargrove, W Preiser, H Slabbert, G Van Zyl, J Levin, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 53 (4), 496-499, 2010
|HIV-1 drug resistance mutations: potential applications for point-of-care genotypic resistance testing|
SY Rhee, MR Jordan, E Raizes, A Chua, N Parkin, R Kantor, GU Van Zyl, ...
PloS one 10 (12), e0145772, 2015
|Trends in genotypic HIV-1 antiretroviral resistance between 2006 and 2012 in South African patients receiving first-and second-line antiretroviral treatment regimens|
GU Van Zyl, TF Liu, M Claassen, S Engelbrecht, T De Oliveira, W Preiser, ...
PloS one 8 (6), e67188, 2013
|Deep sequencing reveals minor protease resistance mutations in patients failing a protease inhibitor regimen|
R Fisher, GU van Zyl, SAA Travers, SLK Pond, S Engelbrech, B Murrell, ...
Journal of virology 86 (11), 6231-6237, 2012
|Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection|
LG Bekker, K Rebe, F Venter, G Maartens, M Moorhouse, F Conradie, ...
Southern African Journal of HIV Medicine 17 (1), 2016
|Protease inhibitor resistance in South African children with virologic failure|
GU van Zyl, L van der Merwe, M Claassen, MF Cotton, H Rabie, ...
The Pediatric infectious disease journal 28 (12), 1125-1127, 2009
|Pooling strategies to reduce the cost of HIV-1 RNA load monitoring in a resource-limited setting|
GU Van Zyl, W Preiser, S Potschka, AT Lundershausen, R Haubrich, ...
Clinical Infectious Diseases 52 (2), 264-270, 2011
|Antiretroviral resistance patterns and factors associated with resistance in adult patients failing NNRTI‐based regimens in the western cape, South Africa|
GU van Zyl, L van der Merwe, M Claassen, M Zeier, W Preiser
Journal of medical virology 83 (10), 1764-1769, 2011
|HIV drug resistance (HIVDR) in antiretroviral therapy-naive patients in Tanzania not eligible for WHO threshold HIVDR survey is dramatically high|
C Kasang, S Kalluvya, C Majinge, A Stich, J Bodem, G Kongola, ...
PloS one 6 (8), e23091, 2011
|Early Antiretroviral Therapy in South African Children Reduces HIV-1–Infected Cells and Cell-Associated HIV-1 RNA in Blood Mononuclear Cells|
GU van Zyl, MA Bedison, AJ van Rensburg, B Laughton, MF Cotton, ...
The Journal of infectious diseases 212 (1), 39-43, 2015
|No evidence of HIV replication in children on antiretroviral therapy|
GU Van Zyl, MG Katusiime, A Wiegand, WR McManus, MJ Bale, ...
The Journal of clinical investigation 127 (10), 3827-3834, 2017
|Moderate levels of pre-treatment HIV-1 antiretroviral drug resistance detected in the first South African national survey|
K Steegen, S Carmona, M Bronze, MA Papathanasopoulos, G Van Zyl, ...
PloS one 11 (12), e0166305, 2016
|Pitfalls with rapid HIV antibody testing in HIV-infected children in the Western Cape, South Africa|
M Claassen, GU Van Zyl, SNJ Korsman, L Smit, MF Cotton, W Preiser
Journal of clinical virology 37 (1), 68-71, 2006
|Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries …|
MW Tang, SY Rhee, S Bertagnolio, N Ford, S Holmes, KC Sigaloff, ...
The Journal of infectious diseases 207 (suppl_2), S70-S77, 2013
|Guidelines for the management of acute meningitis in children and adults in South Africa|
TH Boyles, C Bamford, K Bateman, L Blumberg, A Dramowski, ...
Southern African Journal of Epidemiology and Infection 28 (1), 5-15, 2013